HIF1A and melanoma: In contrast, miR-33a-3p and miR-33a act as oncosuppressors, binding to the 3′UTR of HIF-1α, suppressing its post-transcriptional expression, and inhibiting proliferation and glycolysis in melanoma cells [108,109].